Open Access<p>A Real-World Study of Dexamethasone Implant in Treatment-Naïve Patients with Diabetic Macular Edema: Efficacy and Correlation Between Inflammatory Biomarkers and Treatment Outcome</p>
Author(s) -
Maria Vadalà,
Valentina Trapani,
Giulia Guarrasi,
Nicasio Ventura,
Massimo Castellucci,
Salvatore Cillino
Publication year - 2020
Publication title -
clinical ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.025
H-Index - 56
eISSN - 1177-5483
pISSN - 1177-5467
DOI - 10.2147/opth.s257775
Subject(s) - medicine , dexamethasone , ophthalmology , diabetic macular edema , edema , pro re nata , visual acuity , macular edema , diabetic retinopathy , implant , retinal , regimen , surgery , diabetes mellitus , bevacizumab , ranibizumab , endocrinology , chemotherapy
There has been an increasing clinical interest in specific retinal parameters as non-invasive biomarkers of retinal inflammation in diabetic macular edema (DME) that have been shown to have prognostic value, such as hyperreflective retinal fields (HRFs) and subfoveal neuroretinal detachment (SND).